Cargando…

Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?

BACKGROUND: Up to one third of HIV-infected individuals with suspected TB are sputum-scarce. The Alere Determine™ TB LAM Ag lateral flow strip test can be used to diagnose TB in HIV-infected patients with advanced immunosuppression. However, how urine LAM testing should be incorporated into testing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabur, Natasha F., Esmail, Aliasgar, Brar, Mantaj S., Dheda, Keertan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745979/ https://www.ncbi.nlm.nih.gov/pubmed/29282005 http://dx.doi.org/10.1186/s12879-017-2914-7

Ejemplares similares

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020)

Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe
por: Zijenah, Lynn Sodai, et al.
Publicado: (2016)

The Diagnostic Accuracy of Urine-Based Xpert MTB/RIF in HIV-Infected Hospitalized Patients Who Are Smear-Negative or Sputum Scarce
por: Peter, Jonathan G., et al.
Publicado: (2012)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
por: Sabur, Natasha F., et al.
Publicado: (2021)

Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis
por: Younis, Hiba, et al.
Publicado: (2019)

Clinical, radiological, and laboratory predictors of a positive urine lipoarabinomannan test in sputum-scarce and sputum-negative patients with HIV-associated tuberculosis in two Johannesburg hospitals
por: Chernick, Lior, et al.
Publicado: (2021)

Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study
por: Gupta-Wright, Ankur, et al.
Publicado: (2019)

Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study
por: Meldau, Richard, et al.
Publicado: (2019)

The diagnostic accuracy of pericardial and urinary lipoarabinomannan (LAM) assays in patients with suspected tuberculous pericarditis
por: Pandie, Shaheen, et al.
Publicado: (2016)

Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis
por: Seid, Getachew, et al.
Publicado: (2022)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
por: Sharma, Surendra K., et al.
Publicado: (2019)

Alone But Supported: A Qualitative Study of an HIV Self-testing App in an Observational Cohort Study in South Africa
por: Janssen, Ricky, et al.
Publicado: (2019)

‘You're only there on the phone’? A qualitative exploration of community, affect and agential capacity in HIV self‐testing using a smartphone app
por: Janssen, Ricky, et al.
Publicado: (2021)

Socioeconomic factors impact the risk of HIV acquisition in the township population of South Africa: A Bayesian analysis
por: Leung Soo, Cindy, et al.
Publicado: (2023)

Development and Evaluation of a Digital HIV Risk Assessment Tool Incorporated Within an App-Based Self-Testing Program
por: Leung Soo, Cindy, et al.
Publicado: (2023)

1513. Evaluating the Incremental Accuracy of HIV Self-Test Together with an App-Based Solution: A Secondary Data Analysis of Trial Data
por: Beecroft, Ashlyn M, et al.
Publicado: (2023)

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting
por: Patel, Vinod B, et al.
Publicado: (2009)

Selection and Application of ssDNA Aptamers to Detect Active TB from Sputum Samples
por: Rotherham, Lia S., et al.
Publicado: (2012)

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria
por: Wood, Robin, et al.
Publicado: (2012)

Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study
por: Nicol, Mark P, et al.
Publicado: (2014)

Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
por: Broger, Tobias, et al.
Publicado: (2020)

Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha
por: Sossen, Bianca, et al.
Publicado: (2021)

Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Comments on the article ‘Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis’
por: Keikha, Masoud
Publicado: (2022)

Isolation and purification of lipoarabinomannan from urine of adults with active TB
por: Cantera, J. L., et al.
Publicado: (2023)

Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?
por: Peter, Jonathan G., et al.
Publicado: (2013)

Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2022)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults
por: Shah, Maunank, et al.
Publicado: (2016)

Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity
por: Paris, Luisa, et al.
Publicado: (2017)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2019)

Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing
por: Peter, Jonny, et al.
Publicado: (2015)

Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients
por: Huerga, Helena, et al.
Publicado: (2020)

Response to “Comments on the article ‘Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis’”
por: Seid, Getachew, et al.
Publicado: (2022)

Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts
por: Kawasaki, Masanori, et al.
Publicado: (2019)

Biomarkers for tuberculosis: the case for lipoarabinomannan
por: Correia-Neves, Margarida, et al.
Publicado: (2019)

A systematic review of utility of urine lipoarabinomannan in detecting tuberculosis among HIV-positive tuberculosis suspects
por: Chatla, Chakrapani, et al.
Publicado: (2021)

Prognostic Value of a Quantitative Analysis of Lipoarabinomannan in Urine from Patients with HIV-Associated Tuberculosis
por: Kerkhoff, Andrew D., et al.
Publicado: (2014)

The Diagnostic Accuracy of Urine Lipoarabinomannan Test for Tuberculosis Screening in a South African Correctional Facility
por: Hanifa, Yasmeen, et al.
Publicado: (2015)

Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts
por: Jones, Aksana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c84ra93hmqeopg41unksc6cjag